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The 1,2,4-triazole, a heterocyclic derivative exhibits important
pharmacological activities such as antifungal (Tsukuda et al.,
1998), anticonvulsant (Ku¨c¸u¨kgu¨zel et al., 2004; Klimesova´
et al., 2004), anti-tubercular (Husain and Amir, 1986), antiox-
idant (Valentina et al., 2009), anti-inﬂammatory (Sahin et al.,
2001), COX-2 inhibition (Navidpour et al., 2006), HIV-I re-
verse transcriptase inhibition (Rosa et al., 2006), cytochrome
P450 inhibition (Sun et al., 2007), anticancer (Demirbas
et al., 2002; Olcay et al., 2006; Holla et al., 2001), antimicrobial
activity (Holla et al., 2001; Mithun et al., 2007; Karthikeyan
et al., 2006; Vicentini et al., 1998; Bayrak et al., 2009a,b),
Aggrecanase-2 (Maingot et al., 2010), etc. Furthermore,
1,2,4-triazole nucleus has been incorporated into a wide variety
of therapeutically interesting molecules that act as better drugs
like Ribavirin (antiviral agent), Rizatriptan (antimigrane
agent), Alprazolam (anxiolytic agent) and Fluconazole, Itrac-
onazole (antifungal agent) (Holla et al., 2006; Jack et al.,
1976). Consequently, there is continuing drive to explore these
pharmacophores for the development of novel molecules with
diverse activities.
Fungal infections have become an important complication
and major cause of morbidity and mortality in immunocom-
promised individuals suffering from tuberculosis, cancer,
AIDS and in organ transplant cases (Pridkin and Jarvis,
1996; Wingard and Leather, 2004). Triazole antifungals (e.g.
ﬂuconazole, lanosterol and voriconazole), act by inhibiting
cytochrome P450 14a-desmethylase (CYP51) and recently
became the most rapidly expanding group of antifungal com-
pounds (Sun et al., 2007). However, their clinical value has
been limited by their relative high risk of toxicity, the emer-
gence of drug resistance, pharmacokinetic deﬁciencies and
insufﬁciencies in their antifungal activities. There is still a need
for genuinely broad-spectrum and low toxic antifungal agents
for the therapy.
Prompted by these observations, it was contemplated to
synthesize some new Schiff bases of 5-aryl-4H-1,2,4-triazole-
3-thiol derivatives with a view to explore their potency as bet-
ter chemotherapeutic agents. Presence of thiol group in the
compounds can bind to the cationic functional group or metal
ion in the active site of the target (Maingot et al., 2010). Schiff
bases derived from various heterocycles were reported to have
cytotoxic, anticonvulsant, antiproliferative, anticancer and
antifungal activities (Karthikeyan et al., 2006; Vicentini
et al., 1998; Bayrak et al., 2009a). In this investigation, all new-
ly synthesized Schiff bases of 5-aryl-4H-1,2,4-triazole-3-thiol
compounds were evaluated for the antifungal activity along
with their in silico pharmacophore, pharmacokinetic and toxic
properties.i Narayana Moorthy, N.S. et al.,
methoxy-phenyl)-4H-1,2,4-triazo2. Material and methods
2.1. Materials
Reagents, starting materials and solvents were purchased from
common commercial suppliers. The melting points were deter-
mined in open capillary method on a Jindal melting point
apparatus and are reported uncorrected. 1H NMR spectra
were recorded on the Bruker NMR using DMSO-d6, TMS (tet-
ramethylsilane) as an internal standard. The FAB mass spectra
were recorded on a JEOL SX 102 Mass spectrometer/data sys-
tem using argon/xenon (6KV, 10 mA) as the FAB gas,
m-nitrobenzyl alcohol (NBA) was used as matrix. IR absorp-
tion spectra were recorded on Jasco FT/IR-470 Plus, using
KBr by the diffuse reﬂectance method. Elemental analysis
was performed on Elementar system. The purity and the pro-
gress of reactions were monitored by thin layer chromatogra-
phy using silica gel-G on glass plate as stationary phase and
ethyl acetate and n-heptane as mobile phase. Visualization
was accomplished with UV light and/or iodine vapour.
2.2. Synthesis of 4-amino-5-(3,5-dimethoxy-phenyl)-4H-
[1,2,4]triazole-3-thiol (3)
A mixture of 3,5-dimethoxy benzoic acid (0.01 mol) and thio-
carbohydrazide (0.01 mol) was placed in a round-bottom ﬂask,
heated until it melted. The mixture was consistently main-
tained at 225 C for 20 min. The product obtained on cooling
was treated with sodium bicarbonate solution to neutralize the
unreacted carboxylic acid if any. The product was then washed
with water and collected by ﬁltration. The solid product was
recrystallized from a mixture of dimethylformamide and etha-
nol. Yield 56%; mp 168–170 C; IR (KBr) t/cm1: 1204
(CAOAC), 1647 (C‚N), 3295 (NAH), 2960 (CH3CAH),
1540 (Ar C‚C), 1346 (C‚N), 1158 (CAS); 1H NMR
(400 MHz, d, DMSO-d6): 3.7 (s, 3H (OCH3)), 3.8 (s, 3H
(OCH3)), 5.2 (s, 2H (NH2)), 6.9–7.3 (t, 3H (ArAH)), 13.7 (s,
1H (SH)); Mass (m/z): 252.1 [M+H]+.
2.3. General procedure for the preparation containing Schiff base
derivatives
To a suspension of substituted benzaldehyde (2) (0.2 mol) in
ethanol (1 ml), an equimolar amount of corresponding amino
mercaptotriazole (3) was added. The suspension was heated
until a clear solution was obtained. Then few drops of concen-
trated sulphuric acid were added and the solution was heated
under reﬂux for 4 h on a water-bath. The precipitated solid
was ﬁltered off and recrystallized from a mixture of ethanol
and dimethylformamide.Synthesis, antifungal evaluation and in silico study of novel Schiﬀ
l-3-thiol. Arabian Journal of Chemistry (2014), http://dx.doi.org/
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Figure 1 Scheme for synthesis of Schiff bases of 4-amino-5(3,5-
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IR (KBr) t/cm1: 1207 (CAOAC), 1647 (C‚N), 3346 (NAH),
2956 (CH3CAH), 1541 (Ar C‚C), 1365 (C‚N), 1159 (CAS),
1051 (CACl); 1H NMR (400 MHz, d, DMSO-d6): 3.8 (s, 3H
(OCH3)), 3.9 (s, 3H (OCH3)), 6.57–7.8 (m, 7H (ArAH)), 10.0
(s, 1H. (HC‚N)), 13.7 (s, 1 H (SH)); Mass (m/z): 375.1
[M+H]+.
2.3.2. Compound 5b
IR (KBr) t/cm1: 1204 (CAOAC), 1647 (C‚N), 3647 (NAH),
1541 (Ar C‚C), 1358 (C‚N), 1165 (CAS), 1051 (CACl); 1H
NMR (400 MHz, d, DMSO-d6): 3.7 (s, 3H (OCH3)), 3.8 (s, 3H
(OCH3)), 6.5–8.1 (m, 6H (ArAH)), 10.7 (s, 1H (HC‚N)), 13.9
(s, 1H (SH)); Mass (m/z): 410.1 [M+H]+.
2.3.3. Compound 5c
IR (KBr) t/cm1: 1202 (CAOAC), 1647 (C‚N), 3295 (NAH),
2959 (CH3CAH), 1540 (Ar C‚C), 1367 (C‚N), 1159 (CAS);
1H NMR (400 MHz, d, DMSO-d6): 3.7–3.9 (tris s, 9H,
(OCH3)), 6.5–7.8 (m, 7H. (ArAH)), 9.7 (s, 1H. (HC‚N)),
13.9 (s, 1 H (SH)); Mass (m/z): 371.1 [M+H]+.
2.3.4. Compound 5d
IR (KBr) t/cm1: 1205 (CAOAC), 1688 (C‚N), 3648 (NAH),
2941 (CH3CAH), 1540 (Ar C‚C), 1342 (C‚N), 1157 (CAS);
1H NMR (400 MHz, d, DMSO-d6): 3.7 (s, 3H (OCH3)), 3.9 (s,
3H (OCH3)), 6.5–7.3 (m, 6H (ArAH)), 9.9 (s, 1H (HC‚N)),
13.8 (s, 1H (SH)); Mass (m/z): 349.1 [M+H]+.
2.3.5. Compound 5e
IR (KBr) t/cm1: 1207 (CAOAC), 1647 (C‚N), 3648 (NAH),
2932 (CH3CAH), 1540 (Ar C‚C), 1375 (C‚N), 1167 (CAS);
1H NMR (400 MHz, d, DMSO-d6): 2.5, s, 3H (CH3), 2.7 (s, 3H
(CH3)), 3.1 (s, 2H (NH2)), 3.8 (s, 3H (OCH3)), 3.9 (s, 3H
(OCH3)), 6.5–9.7 (m, 5H (ArAH)), 9.5 (s, 1H (HC‚N)),
13.8 (s, 1H (SH)); Mass (m/z): 385.4 [M+2].
2.3.6. Compound 5f
IR (KBr) t/cm1: 1209 (CAOAC), 1647 (C‚N), 3647 (NAH),
2939 (CH3CAH), 1541 (Ar C‚C), 1367 (C‚N), 1165 (CAS),
1165–1209 (CAOH), 3613 (OAH); 1H NMR (400 MHz, d,
DMSO-d6): 2.8 (s, 1H (OH)), 3.7 (s, 3H (OCH3)), 3.8 (s, 3H
(OCH3)), 6.5–7.7 (m, 7H (ArAH)), 9.8 (s, 1H (HC‚N)),
13.7 (s, 1H (SH)); Mass (m/z): 357.1 [M+H]+.
2.4. Antifungal studies
Antifungal activity of the compounds was performed by the
broth dilution method (MIC method).
2.4.1. Preparation of solution
DMSO stock solutions (1 mg/ml) of all compounds were pre-
pared with 50% DMSO in a screw capped vial. They were
stored at 40 C in the dark.
2.4.2. Preparation of inoculums
Sland culture of Candida albicans was inoculated into a SDB
(Sabour and Dextrose Broth) medium in a conical ﬂask and
incubated at 35 C for 24 h in a shaker. After incubation, thePlease cite this article in press as: Hari Narayana Moorthy, N.S. et al.,
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10.1016/j.arabjc.2013.12.021turbidity was compared with 0.5 Mc Farland Nephalometric
standards (1.5 · 108 CFU) and adjusted with sterile saline.
2.4.3. Preparation of medium
Yeast Nitrogen Base (YNB) (HiMedia) with added agar
(1.7%) and glucose (0.5%) were prepared and poured into pet-
ri plates. A well mixed standardized inoculum was uniformly
spread over the surface of the nutrient broth agar plates with
the help of sterile swab. After 15 min of inoculum, 6–7 mm
diameter wells were made by well puncture and were ﬁlled with
100 ll of each sample stock solution and the control wells were
ﬁlled with 50% DMSO. Then the plates were incubated at
35 C for 24 h. After incubation, the zone of inhibition around
the well was measured including the diameter of the wells.
2.4.4. Broth dilution method/micro dilution
The synthetic compounds that showed considerable antifungal
activities were selected for the study. By this microdilution
method, minimal inhibitory concentration (MIC) was found
out using Amphotericin-B (potency 750 lg/mg) as a standard
drug. All stock solutions (100 lg/ml) were prepared in 100%
DMSO. 102 ll of stock solution was taken in a sterile test tube
and made up to 2 ml with sterile YNB (0.5%) medium, which
gave 512 lg/ml concentration. This content was serially diluted
with 1 ml of sterile YNB broth taken in a test tube to 1 lg/ml
concentration of drug. Experimental tubes were inoculated
with 1 ll of standardized inoculum of C. albicans. Control
tubes with DMSO (51 lg/ml) without drug and medium were
also inoculated with C. albicans. The tubes were incubated atdimethoxy-phenyl)-4H-1,2,4-triazole-3-thiol derivatives.
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Table 1 Physiochemical characterization data of the synthesized compounds.
Compound No. Molecular formula Melting point (C) Yield (%) Elemental analysis
C H N
Exp Calc Exp Calc Exp Calc
5a C17H15ClN4O2S 212–213 60.19 54.42 54.47 4.05 4.03 14.97 14.95
5b C17H14Cl2N4O2S 222–223 66.65 49.95 49.89 3.43 3.45 13.65 13.69
5c C18H18N4O3S 198–201 76.59 58.39 58.36 4.91 4.90 15.07 15.12
5d C15H14N4O3S 188–190 68.40 54.50 54.53 4.28 4.27 16.98 16.96
5e C19H21N5O2S 225–228 50.56 59.57 59.51 5.50 5.52 18.24 18.26
5f C17H16N4O3S 218–219 64.99 57.35 57.29 4.50 4.52 15.69 15.72
Table 2 Drug likeliness of the synthesized compounds.
Compound No. Molecular weight LogP HBD HBA Score
5a 374.87 5.14 1 5 1
5b 409.31 5.81 1 5 1
5c 370.46 4.48 1 6 0
5d 348.46 2.98 1 6 0
5e 383.51 4.34 2 5 0
5f 356.43 4.13 2 6 0
Table 3 Antifungal activity, predicted hERG and LD50 value
of the synthesized triazole derivatives.
Compound
No.
Concentration
(lg/ml)
Growth
inhibition
(mm)
Predicted
hERG
(logIC50)
Predicted
(logLD50)
5a 64 34 6.3 1.6
5b 64 30 6.6 1.3
5c 512 – 6.2 1.3
5d 512 – 4.6 1.5
5e 512 – 6.6 1.7
5f 128 20 6.8 1.7
DMSO Nil –
4 N.S. Hari Narayana Moorthy et al.35 C for 24 h and the concentration of drugs were determined
(measured the turbidity of the medium).
2.5. In silico ADME-Tox study
The Pentium IV work station and Pallas 6.1.1, q-hERG and q-
Tox softwares were used to predict the ADME-T properties of
the molecules (Pallas, 2000; q-Tox, 2008). Chemdraw ultra
software was used to draw the structure of the compounds
to be analysed and was saved as MDL ﬁle.Figure 2 Pharmacophore and SAR of the
Please cite this article in press as: Hari Narayana Moorthy, N.S. et al.,
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The Molecular Operating Environment (MOE) software
(MOE, 2007) was used to optimize the energy of the synthe-
sized molecules before undergoing conformational analysis
(by stochastic search method). The conformers were ﬂexi-
aligned and its pharmacophore sites were investigated.
3. Result and discussions
4-Amino-5(3,5-dimethoxy-phenyl)-4H-1,2,4-triazol-3-thiol (3)
derivatives were synthesized from 3,4-dimethoxy benzoic acid
(1) and thiocarbohydrazide (2) as per the literature (Pridkin
and Jarvis, 1996; Wingard and Leather, 2004; Bayrak et al.,
2009a). Intermediate compound 3 was treated with substituted
aromatic aldehydes (4) in the presence of concentrated H2SO4,
yielded Schiff bases (5) (Fig. 1). The envisaged structures of the
synthesized compounds were conﬁrmed by (Table 1) NMR,
IR, Mass and elemental analysis. All the synthesized com-
pounds underwent antifungal evaluation against C. albicans
strains up to 512 lg/ml concentration. The results obtained
from the evaluation study are provided in Table 2 and it ex-
plains that the monochloro and dichlorophenyl (5a and 5b)
substituents on parent nucleus have signiﬁcant antifungal
activity at 64 lg/ml against C. albicans. The hydroxy phenyl
derivatives (5f) also have considerable activity at 128 lg/ml,
but other substituents such as amino phenyl, furan and meth-
oxy phenyl derivatives (5c) did not possess antifungal activity
till 512 lg/ml concentration.
In order to predict the drug likeliness of the synthesized
compounds, Lipinski rule of 5 was tested (Molecular
weight > 500, LogP> 5, HBD> 5 and HBA> 10), on the
synthesized compounds using Pallas 3.1.1.2 software (Pallas,
2000; Oprea, 2002; Moorthy et al., 2006, 2010). The predicted
properties such as LogP, drug likeliness of the compounds
(Table 2) revealed that the molecules passed Lipinski’s ruleﬂexialigned structure of the compounds.
Synthesis, antifungal evaluation and in silico study of novel Schiﬀ
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Figure 3 Molecular surface property of the ﬂexialigned
compounds.
Synthesis, antifungal evaluation and in silico study 5of 5. The results showed that molecular weight plays an impor-
tant role and causes the bulkiness of the molecules. It explains
that, if the molecular weight increases beyond a limit, the bulk-
iness of the compounds also increases, which affects the drug
action. Molecular weight of the synthesized compounds lying
between 348 and 410 shows that it follows Lipinski rule of 5.
The lipophilicity (LogP) is also an important parameter for
drug action (membrane transport) (Oprea, 2002). It is interest-
ing that the LogP values of chloro and dichlorophenyl substi-
tuted compounds are more than 5, but both are having better
antifungal activity than rest of the compounds which have
Lipinski score 1.
The cardiotoxicity (hERG) and the LD50 values calculated
with q-hERG and q-Tox software and the results are provided
in Table 3. The predicted toxicity (LD50) described that the di-
chloro substituted compound (5b) has comparatively more
toxicity than other compounds in the series, it may be caused
by a high lipophilic property of the molecules. The furan
substituted compound (5d) has less toxicity and free from anti-
fungal activity. The human ether a go-go related gene (hERG)
cause sudden death (prolongation of QT interval) of patient
when non-antiarrhythmic drugs administered that is a major
pharmacological safety issue (Aronov, 2005; Choe et al.,
2006; Moorthy et al., 2012, 2013). Hence, the evaluation of
hERG blocking effect of the molecules in the early stage of
drug discovery provides safe drugs. The results derived from
these studies show that the furan ring containing compounds
have less hERG blocking activity than other aryl ring substi-
tuted compounds. It reveals that the presence of aromatic rings
with ﬂexible bonds makes p–p interaction with the aromatic
residues present in the protein which provides hydrophobicity
to the molecules. Unfortunately, the compound with furan
ring (5d) posses no antifungal activity till 512 lg/ml. The com-
pound substituted with dichloro substituents (5b) on the phe-
nyl ring exhibits signiﬁcant antifungal activity at 64 lg/ml
and this compound has lethal effect at high concentration.
These results also conﬁrm that the chlorine substituents (5a
and 5b) in molecule have signiﬁcant activity with optimized
pharmacokinetic properties.
The pharmacophore contour of the ﬂexialigned compounds
are provided in Fig. 2, which showed that the aromatic/hydro-
phobic and aromatic/acceptor/donor contours are important
pharmacophore contours for the activities. This result also re-
veals that the hydrophobicity plays an important role for the
activity. The molecular surface (Fig. 3) properties of the mol-
ecule also conﬁrm the same result that the hydrophobicity is
distributed throughout the surface areas (grey colour).Please cite this article in press as: Hari Narayana Moorthy, N.S. et al.,
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From the study, it has been concluded that some of the 4-ami-
no-5(3,5-dimethoxy-phenyl)-4H-1,2,4-triazole-3-thiol deriva-
tives have considerable antifungal activity against C.
albicans, and are free from toxicity. Hence, it may be the better
pharmacophore to explore the development of new bioactive
moieties. The in silico predicted toxicity (hERG and LD50)
guides us for further in vitro and in vivo toxicity studies.Acknowledgments
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